Status:
RECRUITING
Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Lung Cancer Stage IV
Eligibility:
All Genders
18+ years
Brief Summary
The distribution of demographic, clinical, radiological, pathological and molecular characteristics of lung cancer at the time of diagnosis, as well as preferential association between elements of tho...
Eligibility Criteria
Inclusion
- Age \>18 years
- Suspicion of lung cancer based on imaging (CT and/or PET/CT)
- Indication to a biopsy for diagnosis, staging and/or molecular profiling
Exclusion
- Inability or unwillingness to provide a written informed consent
- ECOG performance status (\>3) which makes a tissue diagnosis unfeasible
- ASA 4 status
- TNM Stage I-III
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06076005
Start Date
November 1 2023
End Date
August 31 2026
Last Update
September 2 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Interventional Pulmonology Division - Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Italy
2
Istituto Nazionale Tumori Regina Elena
Roma, Italy
3
Medical Oncology Division - Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Italy